Wave Life Sciences (WVE) EBT Margin (2015 - 2026)
Wave Life Sciences posted quarterly EBT Margin of 68.21% for Q1 2026, up 44272.0% year-on-year from N/an in Q1 2025, and up 88.24% on a QoQ basis from 580.17% in Q2 2025.
Wave Life Sciences (WVE) has 12 years of EBT Margin data on file, last reported at 68.21% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 44272.0% year-over-year to 68.21%; the trailing twelve-month figure through Mar 2026 stood at 242.16% (down 8274.0% YoY), and the FY2025 full-year result was 478.33%, down 38876.0% from the prior year.
- EBT Margin for Q1 2026 stood at 68.21%, up from 580.17% in the prior quarter.
- Across five years, EBT Margin topped out at 13.36% in Q3 2023 and bottomed at 13685.61% in Q3 2022.
- The 5-year median for EBT Margin is 251.7% (2024), against an average of 2481.52%.
- The widest annual swing landed in 2022, when EBT Margin sank 1366851 bps; it then surged 1369897 bps in 2023.
- A 5-year view of EBT Margin shows it stood at 3472.8% in 2022, then surged by 98 bps to 55.95% in 2023, then sank by 199 bps to 167.19% in 2024, then plunged by 247 bps to 580.17% in 2025, then surged by 88 bps to 68.21% in 2026.
- The last three EBT Margin figures came in at 68.21% (Q1 2026), 580.17% (Q2 2025), and 510.93% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 18.99% |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | -68.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.21% |
| Jun 30, 2025 | -580.17% |
| Mar 31, 2025 | -510.93% |
| Jun 30, 2024 | -167.19% |
| Mar 31, 2024 | -251.70% |
| Dec 31, 2023 | -55.95% |
| Sep 30, 2023 | 13.36% |
| Jun 30, 2023 | -95.47% |
| Mar 31, 2023 | -211.97% |
| Dec 31, 2022 | -3,472.80% |
| Sep 30, 2022 | -13,685.61% |
| Jun 30, 2022 | -11,012.27% |
| Mar 31, 2022 | -2,160.80% |
| Dec 31, 2021 | -1,982.38% |
| Sep 30, 2021 | -17.10% |
| Jun 30, 2021 | -1,396.47% |
| Dec 31, 2020 | -313.91% |
| Sep 30, 2020 | -959.42% |
| Jun 30, 2020 | -1,338.88% |
| Mar 31, 2020 | -1,141.38% |
| Dec 31, 2019 | -2,365.42% |
| Sep 30, 2019 | -1,731.85% |
| Jun 30, 2019 | -549.84% |
| Mar 31, 2019 | -1,460.67% |
| Dec 31, 2018 | -1,049.45% |
| Sep 30, 2018 | -837.55% |
| Jun 30, 2018 | -735.68% |
| Mar 31, 2018 | -2,466.17% |
| Dec 31, 2017 | -2,822.04% |
| Sep 30, 2017 | -1,970.49% |
| Jun 30, 2017 | -2,210.94% |
| Mar 31, 2017 | -5,218.28% |
| Dec 31, 2016 | -2,760.06% |
| Sep 30, 2016 | -4,375.26% |
| Jun 30, 2016 | -2,761.87% |
| Jun 30, 2015 | -2,897.62% |
| Mar 31, 2015 | -13,134.62% |